The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 06, 2026

Filed:

Mar. 26, 2025
Applicant:

Natron Energy, Inc., Santa Clara, CA (US);

Inventors:

Ashenafi Damtew Mamuye, Saratoga, CA (US);

Daniel Friebel, San Carlos, CA (US);

Assignee:

Natron Energy, Inc., Santa Clara, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C01C 3/12 (2006.01); H01M 10/054 (2010.01);
U.S. Cl.
CPC ...
C01C 3/12 (2013.01); H01M 10/054 (2013.01); C01P 2002/72 (2013.01); C01P 2002/82 (2013.01); C01P 2004/03 (2013.01); C01P 2004/51 (2013.01); C01P 2004/61 (2013.01); C01P 2006/11 (2013.01); C01P 2006/40 (2013.01);
Abstract

Embodiments describe a scalable method for synthesizing Prussian White transition metal cyanide coordination compounds (TMCCC) of the general formula NaFe[Fe(CN)]n HO for use in battery electrodes. This method involves the controlled decomposition of sodium hexacyanoferrate decahydrate using formic acid, where particle size distribution is precisely controlled by modulating nucleation and growth. The process also includes a sodiation step using an aqueous buffer and a reducing agent. The synthesized materials exhibit high capacity and enable the commercialization of sodium-ion batteries, with the added benefit of byproduct processing. The method ensures precise regulation of particle size and morphology, leading to structural uniformity, and allows for tailoring tap density to optimize volumetric energy density. The resulting TMCCC demonstrates zero to low vacancy content and has a confirmed monoclinic phase.


Find Patent Forward Citations

Loading…